Log In
BCIQ
Print this Print this
 

Sotirimod

  Manage Alerts
Collapse Summary General Information
Company Mylan N.V.
DescriptionNot disclosed
Molecular Target
Mechanism of ActionImmune modulation
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationActinic keratosis
Indication DetailsTreat actinic keratosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today